Proteomic applications of protein quantification by isotope-dilution mass spectrometry

References

• André P, de Leenheer LMT. Applications of isotope-dilution mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology. Mass Spec. Rev.11(4), 249–307 (1992).
   Google Scholar
• Kippen AD, Cerini F, Vadas L et al. Development of an isotope-dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay. J. Biol. Chem.272(19), 12513–12522 (1997).
   PubMed Web of Science ®Google Scholar
• Barr JR, Maggio VL, Patterson DG Jr et al. Isotope-dilution mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin. Chem.42(10), 1676–1682 (1996).
   PubMed Web of Science ®Google Scholar
• Barnidge DR, Dratz EA, Martin T et al. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem.75(3), 445–451 (2003).
   PubMed Web of Science ®Google Scholar
• Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl Acad. Sci. USA100(12), 6940–6945 (2003).
   PubMed Web of Science ®Google Scholar
• Barnidge DR, Goodmanson MK, Klee GG, Muddiman DC. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope-dilution mass spectrometry. J. Proteome Res.3(3), 644–652 (2004).
   PubMed Web of Science ®Google Scholar
• Bronstrup M. Absolute quantification strategies in proteomics based on mass spectrometry. Expert Rev. Proteomics1(4), 503–512 (2004).
   PubMed Web of Science ®Google Scholar
• Mayya V, Rezaul K, Wu L, Fong MB, Han DK. Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin dependent kinases. Mol. Cell Proteomics5(6), 1146–11577 (2006).
   PubMed Web of Science ®Google Scholar
• Kirkpatrick DS, Gerber SA, Gygi SP. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods35(3), 265–273 (2005).
   PubMed Web of Science ®Google Scholar
• Richardson CJ, Broenstrup M, Fingar DC et al. SKAR is a specific target of S6 kinase 1 in cell growth control. Curr. Biol.14(17), 1540–1549 (2004).
   PubMed Web of Science ®Google Scholar
• Cutillas PR, Khwaja A, Graupera M et al. Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. Proc. Natl Acad. Sci. USA103(24), 8959–8964 (2006).
   PubMedGoogle Scholar
• Kirkpatrick DS, Hathaway NA, Hanna J et al. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol.8(7), 700–710 (2006).
   PubMed Web of Science ®Google Scholar
• Berger SL. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev.12(2), 142–148 (2002).
   PubMed Web of Science ®Google Scholar
• Ueberheide BM, Taverna SD, Allis CD, Shabanowitz J, Hunt DF. Breaking the histone code: analyzing the interdependence of acetylation and methylation on histone H3 using electron transfer dissociation (ETD). Presented at: 54th Annual ASMS Conference. Seattle, WA, USA, 28th May–1st June (2006).
   Google Scholar
• Jenkins RE, Kitteringham NR, Hunter CL et al. Relative and absolute quantitative expression profiling of cytochrome P450 using isotope-coded affinity tags. Proteomics6(6), 1934–1947 (2006).
   PubMed Web of Science ®Google Scholar
• Alberts B. The cell as a collection of protein machines: preparing the next generation of molecular biologists. Cell92(3), 291–294 (1998).
   PubMed Web of Science ®Google Scholar
• Gingras AC, Aebersold R, Raught B. Advances in protein complex analysis using mass spectrometry. J. Physiol.563(Pt 1), 11–21 (2005).
   PubMed Web of Science ®Google Scholar
• Sobott F, Robinson CV. Protein complexes gain momentum. Curr. Opin. Struct. Biol.12(6), 729–734 (2002).
   PubMed Web of Science ®Google Scholar
• Hochleitner EO, Kastner B, Frohlich T et al. Protein stoichiometry of a multiprotein complex, the human spliceosomal U1 small nuclear ribonucleoprotein: absolute quantification using isotope-coded tags and mass spectrometry. J. Biol. Chem.280(4), 2536–2542 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng D, Hoogenraad CC, Rush J et al. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol. Cell Proteomics5(6), 1158–1170 (2006).
   PubMed Web of Science ®Google Scholar
• Peng J, Kim MJ, Cheng D et al. Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J. Biol. Chem.279(20), 21003–21011 (2004).
   PubMed Web of Science ®Google Scholar
• Shi Y. Caspase activation: revisiting the induced proximity model. Cell117(7), 855–858 (2004).
   PubMed Web of Science ®Google Scholar
• Rout MP, Aitchison JD, Suprapto A et al. The yeast nuclear pore complex: composition, architecture, and transport mechanism. J. Cell Biol.148(4), 635–651 (2000).
   PubMed Web of Science ®Google Scholar
• Kuhn E, Wu J, Karl J et al. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics4(4), 1175–1186 (2004).
   PubMed Web of Science ®Google Scholar
• Hwang SI, Thumar J, Lundgren DH et al. Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene (2006) (Epub ahead of print).
   Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics1(11), 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Rogatsky E, Balent B, Goswami G et al. Sensitive quantitative analysis of C-peptide in human plasma by 2-dimensional liquid chromatography–mass spectrometry isotope-dilution assay. Clin. Chem.52(5), 872–879 (2006).
   PubMedGoogle Scholar
• Fierens C, Stockl D, Baetens D, De Leenheer AP, Thienpont LM. Standardization of C-peptide measurements in urine by method comparison with isotope-dilution mass spectrometry. Clin. Chem.49(6 Pt 1), 992–994 (2003).
   PubMed Web of Science ®Google Scholar
• Hawkridge AM, Heublein DM, Bergen HR 3rd et al. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc. Natl Acad. Sci. USA102(48), 17442–17447 (2005).
   PubMed Web of Science ®Google Scholar
• Veenstra TD, Hood BL, Krizman DB et al. Development of a method for quantification of HER-2 in formalin-fixed paraffin embedded breast cancer tissue and serum. Presented at: 54th Annual ASMS Conference. Seattle, WA, USA, 28th May–1st June (2006).
   Google Scholar
• Bagnato C, Thumar J, Mayya V et al. Proteomic analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell Proteomics (2006) (Submitted).
   Google Scholar
• Anderson NL. The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol. Cell Proteomics4(10), 1441–1444 (2005).
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24(8), 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Pan S, Zhang H, Rush J et al. High throughput proteome screening for biomarker detection. Mol. Cell Proteomics4(2), 182–190 (2005).
   PubMed Web of Science ®Google Scholar
• Kuster B, Schirle M, Mallick P, Aebersold R. Scoring proteomes with proteotypic peptide probes. Nat. Rev. Mol. Cell Biol.6(7), 577–583 (2005).
   PubMed Web of Science ®Google Scholar
• Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics5(4), 573–588 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG, Haines LR et al. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by antipeptide antibodies (SISCAPA). J. Proteome Res.3(2), 235–244 (2004).
   PubMed Web of Science ®Google Scholar
• Wu L, Han DK. Strategies to overcome the dynamic range problem in mass spectrometry based proteomics. Expert Rev. Proteomics Submitted (2006) (In Press).
   PubMedGoogle Scholar
• Aebersold R. A mass spectrometric journey into protein and proteome research. J. Am. Soc. Mass Spectrom.14(7), 685–695 (2003).
   PubMed Web of Science ®Google Scholar
• Aebersold R. Molecular systems biology: a new journal for a new biology? 1(1), msb4100009-E4100001-msb4100009-E4100002 (2005).
   Google Scholar
• Janes KA, Gaudet S, Albeck JG et al. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell124(6), 1225–1239 (2006).
   PubMedGoogle Scholar
• Janes KA, Albeck JG, Gaudet S et al. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science310(5754), 1646–1653 (2005).
   PubMed Web of Science ®Google Scholar
• Sachs K, Perez O, Pe'er D, Lauffenburger DA, Nolan GP. Causal protein-signaling networks derived from multiparameter single-cell data. Science308(5721), 523–529 (2005).
   PubMed Web of Science ®Google Scholar
• Beynon RJ, Doherty MK, Pratt JM, Gaskell SJ. Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides. Nat. Methods2(8), 587–589 (2005).
   PubMed Web of Science ®Google Scholar
• Pipkorn R, Boenke C, Gehrke M, Hoffmann R. High-throughput peptide synthesis and peptide purification strategy at the low micromole-scale using the 96-well format. J. Pept. Res.59(3), 105–114 (2002).
   PubMedGoogle Scholar
• Domon B, Aebersold R. Mass spectrometry and protein analysis. Science312(5771), 212–217 (2006).
   PubMed Web of Science ®Google Scholar
• Domon B, Zheng-Stahl J, Aebersold R. Novel strategy for rapid screening and quantification of biomarkers in serum. Presented at: 54th Annual ASMS Conference. Seattle, WA, USA, 28th May–1st June (2006).
   Google Scholar
• Unwin RD, Griffiths JR, Leverentz MK et al. Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity. Mol. Cell Proteomics4(8), 1134–1144 (2005).
   PubMed Web of Science ®Google Scholar
• Lam H, Deutsch E, Eddes J et al. SpectraST: an open-source MS/MS spectra-matching library search tool for targeted proteomics. Presented at: 54th Annual ASMS Conference. Seattle, WA, USA, 28th May–1st June (2006).
   Google Scholar
• Stein S, Kilpatrick L, Mautner M, Neta P, Roth J. Building and using reference libraries of peptide mass spectra. Presented at: 53rd Annual ASMS Conference, San Antonio, TX, USA, 5th–9th June (2005).
   Google Scholar
• Cohen P. The regulation of protein function by multisite phosphorylation – a 25 year update. Trends Biochem. Sci.25(12), 596–601 (2000).
   PubMed Web of Science ®Google Scholar
• Roach PJ. Multisite and hierarchal protein phosphorylation. J. Biol. Chem.266(22), 14139–14142 (1991).
   PubMed Web of Science ®Google Scholar
• Nash P, Tang X, Orlicky S et al. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature414(6863), 514–521 (2001).
   PubMed Web of Science ®Google Scholar
• Karin M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene18(49), 6867–6874 (1999).
   PubMed Web of Science ®Google Scholar
• Welcker M, Singer J, Loeb KR et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol.Cell12(2), 381–392 (2003).
   PubMed Web of Science ®Google Scholar
• Holmberg CI, Tran SE, Eriksson JE, Sistonen L. Multisite phosphorylation provides sophisticated regulation of transcription factors. Trends Biochem. Sci.27(12), 619–627 (2002).
   PubMed Web of Science ®Google Scholar
• Diviani D, Lattion AL, Cotecchia S. Characterization of the phosphorylation sites involved in G protein-coupled receptor kinase- and protein kinase C-mediated desensitization of the α1B-adrenergic receptor. J. Biol. Chem.272(45), 28712–28719 (1997).
   PubMed Web of Science ®Google Scholar
• Guo J, Wu Y, Zhang W et al. Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated δ-opioid receptor phosphorylation. Mol. Pharmacol.58(5), 1050–1056 (2000).
   PubMed Web of Science ®Google Scholar
• Dougherty MK, Muller J, Ritt DA et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell17(2), 215–224 (2005).
   PubMed Web of Science ®Google Scholar
• Gietzen KF, Virshup DM. Identification of inhibitory autophosphorylation sites in casein kinase I epsilon. J. Biol. Chem.274(45), 32063–32070 (1999).
   PubMed Web of Science ®Google Scholar
• Yang XJ. Multisite protein modification and intramolecular signaling. Oncogene24(10), 1653–1662 (2005).
   PubMed Web of Science ®Google Scholar
• Berger SL. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev.12(2), 142–148 (2002).
   PubMed Web of Science ®Google Scholar
• Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol.Cell2(2), 233–239 (1998).
   PubMed Web of Science ®Google Scholar
• Bulavin DV, Higashimoto Y, Demidenko ZN et al. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat. Cell Biol.5(6), 545–551 (2003).
   PubMedGoogle Scholar
• Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell Biol.13(12), 7418–7428 (1993).
   PubMed Web of Science ®Google Scholar
• Agalioti T, Chen G, Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell111(3), 381–392 (2002).
   PubMed Web of Science ®Google Scholar
• Kanno T, Kanno Y, Siegel RM et al. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell13(1), 33–43 (2004).
   PubMed Web of Science ®Google Scholar
• Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J.9(10), 919–925 (1995).
   PubMed Web of Science ®Google Scholar
• Zhang X, Ibrahimi OA, Olsen SK et al. Receptor specificity of the fibroblast growth factor family, part II. J. Biol. Chem.281(23), 15694–15700 (2006).
   PubMed Web of Science ®Google Scholar
• Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol.2(3), REVIEWS3005 (2001).
   PubMed Web of Science ®Google Scholar
• Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet.20(11), 563–569 (2004).
   PubMed Web of Science ®Google Scholar
• Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell74(4), 597–608 (1993).
   PubMed Web of Science ®Google Scholar
• Minn AJ, Boise LH, Thompson CB. Bcl-x(S) anatagonizes the protective effects of Bcl-x(L). J. Biol.Chem.271(11), 6306–6312 (1996).
   PubMed Web of Science ®Google Scholar
• McKenney DW, Onodera H, Gorman L, Mimura T, Rothstein DM. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J. Biol. Chem.270(42), 24949–24954 (1995).
   PubMedGoogle Scholar
• Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol.3(8), 764–771 (2002).
   PubMed Web of Science ®Google Scholar
• Onodera H, Motto DG, Koretzky GA, Rothstein DM. Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase. J. Biol. Chem.271(36), 22225–22230 (1996).
   PubMedGoogle Scholar
• Chang DW, Xing Z, Pan Y et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. Embo. J.21(14), 3704–3714 (2002).
   PubMed Web of Science ®Google Scholar
• Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell Biol.21(24), 8247–8254 (2001).
   PubMed Web of Science ®Google Scholar
• Micheau O, Thome M, Schneider P et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem.277(47), 45162–45171 (2002).
   PubMedGoogle Scholar
• Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem.274(3), 1541–1548 (1999).
   PubMed Web of Science ®Google Scholar
• Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol. Rev.81(1), 21–50 (2001).
   PubMed Web of Science ®Google Scholar
• de Melker AA, Sonnenberg A. Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events. Bioessays21(6), 499–509 (1999).
   PubMedGoogle Scholar
• Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol.11(2), 255–260 (1999).
   PubMed Web of Science ®Google Scholar
• Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol.22(6), 328–336 (2001).
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev.13(12), 1501–1512 (1999).
   PubMed Web of Science ®Google Scholar
• Salvesen GS, Duckett CS. IAP proteins: blocking the road to death’s door. Nat. Rev. Mol. Cell Biol.3(6), 401–410 (2002).
   PubMed Web of Science ®Google Scholar
• Sasaki A, Yasukawa H, Suzuki A et al. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells4(6), 339–351 (1999).
   PubMed Web of Science ®Google Scholar
• Simpson L, Parsons R. PTEN: life as a tumor suppressor. Exp. Cell Res.264(1), 29–41 (2001).
   PubMed Web of Science ®Google Scholar
• Funamoto S, Meili R, Lee S, Parry L, Firtel RA. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell109(5), 611–623 (2002).
   PubMed Web of Science ®Google Scholar
• Adachi N, Kimura A, Horikoshi M. A conserved motif common to the histone acetyltransferase Esa1 and the histone deacetylase Rpd3. J. Biol. Chem.277(38), 35688–35695 (2002).
   PubMedGoogle Scholar
• Yoshimura A, Ohkubo T, Kiguchi T et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. Embo. J,14(12), 2816–2826 (1995).
   PubMed Web of Science ®Google Scholar
• Ferrell JE Jr. What do scaffold proteins really do? Sci. STKE2000(52), PE1 (2000).
   PubMedGoogle Scholar
• Levchenko A, Bruck J, Sternberg PW. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc. Natl Acad. Sci. USA 97(11), 5818–5823 (2000).
   PubMed Web of Science ®Google Scholar
• Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol.1(1), E10 (2003).
   PubMed Web of Science ®Google Scholar